Adams and colleagues proposed that the hepatic complications of IBD are mediated by mucosal T cells that are recruited to the portal areas in response to aberrantly expressed mucosal addressin cell-adhesion molecule 1 (MAdCAM1), which is normally restricted to the gut [44]. This evidence concerns the gene MADCAM1 and inflammatory bowel disease.